HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Targets Herbal Remedies Marketed to Hispanics, Settles “Fat Lie” Suit

This article was originally published in The Tan Sheet

Executive Summary

Latinos Group Promotions must notify consumers and resellers of its herbal supplement Arcomig and its powdered tea Essiac Formula that claims made for the products were false and unsupported, according to a stipulated judgment announced by the Federal Trade Commission July 26

You may also be interested in...



Bio Trim settlement

The marketers of glucomannan-based Bio Trim are "permanently prohibited" from making false and misleading claims about weight-loss products, FTC announces Nov. 7. A suspended judgment totaling more than $2.1 mil. in consumer injury will be due immediately if either Natural Products, Natural 4 U or their owner Ana Solkamans are found to have misrepresented their financial status. The complaint is the fifth of six "Operation Big Fat Lie" suits settled since their filing in November 2004 (1"The Tan Sheet" Nov. 15, 2005, p. 14 and 2"The Tan Sheet" August 1, 2005, p. 15)...

FTC “Big Fat Lie” Settlements Half Complete; “Red Flag” Efforts March On

FTC's settlement with the marketer of Himalayan Diet Breakthrough brings the commission to its half-way point in settling the six complaints filed against dietary supplement firms under "Operation Big Fat Lie.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS126906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel